Frequency of cervical intraepithelial neoplasia treatment in a well-screened population

International Journal of Cancer

Volumn 130, Issue 10, 2012, Pages 2438-2444

  Barken, Sidsel Svennekjær ^a   Rebolj, Matejka ^a   Andersen, Erik Søgaard ^b   Lynge, Elsebeth ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

cervical cancer; cervical intraepithelial neoplasia; register; screening; treatment

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CANCER THERAPY; CRYOTHERAPY; DENMARK; ELECTROCOAGULATION; EXCISION; FEMALE; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRIORITY JOURNAL; STANDARDIZATION; TREND STUDY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; EARLY DETECTION OF CANCER; FEMALE; HEALTH SERVICES MISUSE; HUMANS; INCIDENCE; MASS SCREENING; MIDDLE AGED; RISK FACTORS; UTERINE CERVICAL NEOPLASMS;

EID: 84859107511     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.26248     Document Type: Article

References (39)

1. Soutter WP, de Barros LA, Fletcher A, Monaghan JM, Duncan ID, Paraskevaidis E, Kitchener HC,. Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia. Lancet 1997; 349: 978-80. (Pubitemid 27149800)
2. IARC. CI5 I-IX: Cancer Incidence in Five Continents Volumes I to IX. http://ci5.iarc.fr/CI5i-ix/ci5i-ix.htm (accessed Nov 25, 2010).
3. Ostor AG,. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993; 12: 186-92. (Pubitemid 23095196)
4. Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, Martin-Hirsch P, Prendiville W, Paraskevaidis E,. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 2008; 337: a1284.
5. Bevis KS, Biggio JR,. Cervical conization and the risk of preterm delivery. Am J Obstet Gynecol 2011; 205: 19-27.
6. McCredie MR, Sharples KJ, Paul C, Baranyai J, Medley G, Jones RW, Skegg DC,. Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study. Lancet Oncol 2008; 9: 425-34.
7. Schiffman M, Rodriguez AC,. Heterogeneity in CIN3 diagnosis. Lancet Oncol 2008; 9: 404-6. (Pubitemid 351618081)
8. Kalliala I, Anttila A, Pukkala E, Nieminen P,. Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ 2005; 331: 1183-5. (Pubitemid 41689433)
9. Raffle AE, Alden B, Quinn M, Babb PJ, Brett MT,. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ 2003; 326: 901-5.
10. Forsmo S, Buhaug H, Skjeldestad FE, Haugen OA,. Treatment of pre-invasive conditions during opportunistic screening and its effectiveness on cervical cancer incidence in one Norwegian county. Int J Cancer 1997; 71: 4-8. (Pubitemid 27158401)
11. Magnus K, Langmark F, Andersen A,. Mass screening for cervical cancer in Ostfold county of Norway 1959-77. Int J Cancer 1987; 39: 311-6. (Pubitemid 17038185)
12. Sasieni P, Castanon A, Parkin DM,. How many cervical cancers are prevented by treatment of screen-detected disease in young women? Int J Cancer 2009; 124: 461-4.
13. Anttila A, Ronco G,. Description of the national situation of cervical cancer screening in the member states of the European Union. Eur J Cancer 2009; 45: 2685-708.
14. Lynge E, Clausen LB, Guignard R, Poll P,. What happens when organization of cervical cancer screening is delayed or stopped? J Med Screen 2006; 13: 41-6. (Pubitemid 43843764)
15. Styregruppen for DKLS. Årsrapport DKLS 2009: Dansk Kvalitetsdatabase for Livmoderhalskræftscreening [Annual report 2009: Danish Quality Assurance Database for cervical cancer screening]. https://www.sundhed.dk/Artikel.aspx?id=74501.1 (accessed Jan 28, 2011).
16. Anttila A, von Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, Nicula F, Vass L, Valerianova Z, Voti L, Sauvaget C, Ronco G,. Cervical cancer screening policies and coverage in Europe. Eur J Cancer 2009; 45: 2649-58.
17. Sundhedsstyrelsen. Forebyggende undersøgelser mod livmoderhalskræft: Underudvalget vedrørende livmoderhalsundersøgelse [Preventive examinations against cervical cancer: subcommittee concerning cervical examinations]. Copenhagen: Sundhedsstyrelsen, 1986.
18. Andersen ES,. Laser conization in the management of cervical intraepithelial neoplasia and microinvasive carcinoma of the uterine cervix. Aarhus: Faculty of Health Sciences, University of Aarhus, 2001.
19. Andersen ES, Christau S, Jeppesen U, Jochumsen K, Lund N, Lundvall L, Madsen EM, Mogensen O, Mosgaard B, Nielsen D, Palle C, Svane D, et al. Cervical dysplasi. Udredning, behandling og kontrol [Cervical dysplasia. diagnosis, treatment and follow-up]. http://www.dsog.dk/files/DYSPLASI.pdf. (accessed Dec 13, 2010).
20. Søgaard E, Nielsen K, Pedersen S, Jeppesen U,. DSOG Kliniske Guidelines [Danish Society of Obstetrics and Gynaecology Clinical Guidelines]. (accessed Dec 13, 2010).
21. Nellemann G, Abrahamsson LO,. Slyngekonisering af cervix uteri i gynækologisk speciallægepraksis [Loop conization of cervix uteri in gynecological practice]. Ugeskr Laeger 1998; 160: 5783-6. (Pubitemid 128519255)
22. Sundhedsstyrelsen. Det moderniserende Cancerregister-metode og kvalitet [The modernized Cancer Register-method and quality]. Copenhagen: Sundhedsstyrelsen, 2009.
23. Danmarks Statistik. Danmark Statistik-Statistikbanken [StatBank Denmark]. http://www.statistikbanken.dk/statbank5a/default.asp?w=1472 (accessed Aug 23, 2010).
24. Engholm G, Ferlay J, Christensen N, Bray F, Gjerstorff ML, Klint Å, Køtlum JE, Ólafsdóttir E, Pukkala E, Storm HH,. NORDCAN: cancer incidence, mortality, prevalence and prediction in the Nordic Countries, Version 3.5. Association of the Nordic Cancer Registries. Danish Cancer Society. (accessed Dec 15, 2010).
25. Kjaer SK, Breugelmans G, Munk C, Junge J, Watson M, Iftner T,. Population-based prevalence, type- and age-specific distribution of HPV in women before introduction of an HPV-vaccination program in Denmark. Int J Cancer 2008; 123: 1864-70.
26. Kjaer SK, de Villiers EM, Caglayan H, Svare E, Haugaard BJ, Engholm G, Christensen RB, Møller KA, Poll P, Jensen H,. Human papillomavirus, herpes simplex virus and other potential risk factors for cervical cancer in a high-risk area (Greenland) and a low-risk area (Denmark)-a second look. Br J Cancer 1993; 67: 830-7. (Pubitemid 23101569)
27. Svare EI, Kjaer SK, Worm AM, Osterlind A, Moi H, Christensen RB, Meijer CJ, Walboomers JM, van den Brule AJ,. Risk factors for HPV infection in women from sexually transmitted disease clinics: comparison between two areas with different cervical cancer incidence. Int J Cancer 1998; 75: 1-8. (Pubitemid 28113969)
28. Hakama M, Rasanen-Virtanen U,. Effect of a mass screening program on the risk of cervical cancer. Am J Epidemiol 1976; 103: 512-7.
29. van Oortmarssen GJ, Habbema JD,. Epidemiological evidence for age-dependent regression of pre-invasive cervical cancer. Br J Cancer 1991; 64: 559-65.
30. Arbyn M, Simoens C, Van Oyen H, Foidart JM, Goffin F, Simon P, Fabri V,. Analysis of 13 million individual patient records pertaining to Pap smears, colposcopies, biopsies and surgery on the uterine cervix (Belgium, 1996-2000). Prev Med 2009; 48: 438-43.
31. Noehr B, Jensen A, Frederiksen K, Tabor A, Kjaer SK,. Loop electrosurgical excision of the cervix and subsequent risk for spontaneous preterm delivery: a population-based study of singleton deliveries during a 9-year period. Am J Obstet Gynecol 2009; 201: 33-6.
32. Berget A, Andreasson B, Bock JE,. Laser and cryo surgery for cervical intraepithelial neoplasia. A randomized trial with longterm follow-up. Acta Obstet Gynecol Scand 1991; 70: 231-5.
33. Andersen ES, Husth M,. Cryosurgery for cervical intraepithelial neoplasia: 10-year follow-up. Gynecol Oncol 1992; 45: 240-2.
34. Bro F, Svanholm H, Stovring H, Frandsen C,. Utilsigtede hændelser i et vaginalcytologisk screeningsprogram [Adverse incidents in a cervical cancer screening programme]. Ugeskr Laeger 2008; 170: 2794-7.
35. Ingemann-Hansen O, Lidang M, Niemann I, Dinesen J, Baandrup U, Svanholm H, Petersen L,. Screening history of women with cervical cancer: a 6-year study in Aarhus, Denmark. Br J Cancer 2008; 98: 1292-4. (Pubitemid 351481678)
36. European Guidelines for quality assurance in cervical cancer screening, 2nd ed. Luxembourg: Office for Official Publications of the European Communities, 2008.
37. Wright TC, Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D,. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007; 197: 346-55. (Pubitemid 47464164)
38. The ASCUS-LSIL Triage Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003; 188: 1383-92.
39. Abrahamsson LO, Nellemann G,. Elektrokirurgiske slyngeprocedurer i den ambulante gynækologi [Electrosurgical loop procedures in ambulatory gynecology]. Ugeskr Laeger 1998; 160: 5767-71. (Pubitemid 128519253)